| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 25.644 | 98.555 | 83.397 | 137.621 | 256.544 | 124.648 | 149.511 |
| Total Income - EUR | - | - | 0 | 25.644 | 98.555 | 83.397 | 137.622 | 295.041 | 234.726 | 149.573 |
| Total Expenses - EUR | - | - | 2.957 | 45.972 | 67.063 | 98.263 | 138.943 | 230.099 | 236.956 | 278.729 |
| Gross Profit/Loss - EUR | - | - | -2.957 | -20.328 | 31.492 | -14.866 | -1.321 | 64.942 | -2.230 | -129.156 |
| Net Profit/Loss - EUR | - | - | -2.957 | -20.584 | 30.506 | -15.463 | -2.698 | 62.428 | -4.445 | -132.971 |
| Employees | - | - | 0 | 4 | 6 | 8 | 5 | 8 | 3 | 3 |
Check the financial reports for the company - Policlinica Baba Novac S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 99 | 33.034 | 32.547 | 115.130 | 134.633 | 143.274 | 139.571 | 224.985 |
| Current Assets | - | - | 260 | 5.687 | 30.394 | 35.809 | 25.758 | 59.852 | 30.482 | 45.756 |
| Inventories | - | - | 210 | 1.486 | 1.606 | 28.634 | 11.811 | 11.847 | 3.017 | 4.232 |
| Receivables | - | - | 0 | 2.697 | 1.714 | 2.038 | 2.817 | 45.265 | 21.906 | 6.897 |
| Cash | - | - | 50 | 1.504 | 27.073 | 5.137 | 11.130 | 2.741 | 5.559 | 34.627 |
| Shareholders Funds | - | - | -2.914 | -23.444 | 7.516 | -15.243 | -17.603 | 44.771 | -4.264 | 144.323 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 281.575 |
| Debts | - | - | 3.304 | 20.940 | 15.472 | 127.049 | 139.775 | 158.527 | 174.428 | 126.418 |
| Income in Advance | - | - | 0 | 41.226 | 40.006 | 39.247 | 38.377 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Policlinica Baba Novac S.r.l.